Leukemia that begins in myeloid cells is called myeloid, myeloblastic or myelogenous, leukemia. Chronic Myelogenous Leukemia (CML) is a cancer of the blood cells in which too many myeloid cells are m
Featured Treatment Areas
Our Bone Marrow Transplant program is committed to developing leading-edge strategies for autologous and allogeneic bone marrow and peripheral blood stem cell transplantation.
Our leukemia program has state-of-the-art diagnosis and care, as well as access to clinical trials. Our physicians work in consultation with leading hematopathologists and other specialists to provide compassionate and personalized care.
El Centro para la Leucemia del Mass General Cancer Center ofrece tratamientos y ensayos clínicos para todos los tipos de leucemia aguda y crónica y los trastornos de la sangre relacionados.
News & Publications
Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.
News and notes from the largest hospital-based research program in the United States
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.